The core activity of ibita GmbH is the development, manufacture and marketing of products and technologies for aesthetic medicine, regenerative medicine and medical cosmetics. In particular, the company focuses on the following areas: Aesthetic Medicine: Products and technologies for the treatment of skin and body, such as hyaluronic acid fillers, botulinum toxin applications and autologous fat transfer. Regenerative Medicine: Products and technologies for the restoration of degenerated and damaged cells, tissues and organs, such as Stromal Vascular Fraction (SVF) and Platelet Rich Plasma (PRP). Medical Cosmetics: Products and technologies for skin care and treatment, such as microneedling, mesotherapy and aftercare products. The company offers innovative solutions for doctors and medical professionals to effectively treat their patients and improve their skin and appearance.